Ancora Biotech
3 known investors
Ancora Biotech is a privately held biotherapeutics developer overseeing the manufacturing and clinical development of three multi-specific antibodies held in separate spin-offs. Its programs target B cell cancers, inflammatory and metabolic disorders, and chronic hepatitis B infections.
Investors · 3
In the news
Frequently asked questions
- What does Ancora Biotech do?
- Ancora Biotech is a privately held biotherapeutics developer overseeing the manufacturing and clinical development of three multi-specific antibodies held in separate spin-offs. Its programs target B cell cancers, inflammatory and metabolic disorders, and chronic hepatitis B infections.
- Who are Ancora Biotech's investors?
- Ancora Biotech's investors include Lightspeed Venture Partners, Sutter Hill Ventures, SR One Capital Management.